Company / Shares Outstanding
Gain Therapeutics, Inc. Shares Outstanding History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
16.2M
FY2024
5-year range
3.5M / 16.2M
FY2021-FY2024
Trend
+36.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 11883368.00 to 16206680.00 over the past 2 years.
Based on SEC 10-K filings.
16206680.00 in FY2024 with a 3-year CAGR of +66.0%.
Increased from 11883368.00 to 16206680.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +66.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shares outstanding increased 36.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -16.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 16.2M | +36.4% |
| FY2023 | 11.9M | +0.0% |
| FY2022 | 11.9M | +235.4% |
| FY2021 | 3.5M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026